Reactive Driven Support for Treatment, Adherence, Resilience, and Thriving (reSTART) Clinical Trial
Recruiting
N/A
Interventional Study
Behavioral Intervention
Viral Suppression of HIV Infection
ART Adherence
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 70
- Sex
- Male
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 270 (estimated)
- Sponsor
- University of California, San Francisco · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Men who are living with HIV and use stimulants face many challenges and barriers that may interfere with remembering to take their HIV medication. Forgetting to take HIV medication puts men living with HIV at a greater risk of becoming virally unsuppressed. Researchers are doing this study to test if a remote intervention can help participants improve remembering to take their HIV medications and …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Prescribed antiretroviral therapy (ART) with a tenofovir-based regimen.
* Documented virologic non-suppression, urine tenofovir testing without tenofovir detected, or self-reported adherence \<100%.
* Reports stimulant use.
* Has a mailing address within the U.S.
* Currently h…